Landing Med

Landing Med is a medical technology company that was founded in 2000, with a focus on AI-powered early cancer detection solutions. The company has extensively worked in the field of AI, Health Care, and Medical Devices. With a slogan of "AI Cytology & Digital Pathology Solutions", Landing Med has accumulated 10+ million samples and collaborates with 2000+ health organizations to provide intelligent, efficient, and accessible products and services. The company has shown a strong commitment to promoting health equity and serving underprivileged communities. Being a pioneer in AI-assisted population-based cervical cytology screening, Landing Med has utilized cutting-edge technology to screen millions of women in rural regions. Through this, they have saved thousands of lives by detecting cancer at its earliest stages. As of now, there is no available information on Landing Med's last investment or the last investment investors. With its headquarters in China, Landing Med presents itself as an impactful player in the field of medical technology, with a laudable focus on leveraging AI for early cancer detection and promoting health equity.